Similarly, in a UK population-based cohort, Cardwell et al. [13] revealed that users of ACE inhibitors and ATr blockers had a slightly decreased PCa-specific mortality and concluded that it was safe to use these antihypertensive drugs after PCa diagnosis. The gene discussed is ACE; the disease is posterior cortical atrophy.